| # | Drug | Count |
|---|---|---|
| 0 | CERTOLIZUMAB PEGOL | 4 |
| 1 | ERGOCALCIFEROL | 4 |
| 2 | ETANERCEPT | 4 |
| 3 | PREDNISONE | 4 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | ADALIMUMAB | 3 |
| 6 | METRONIDAZOLE | 3 |
| 7 | OMALIZUMAB | 3 |
| 8 | TACROLIMUS | 3 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | BORON | 1 | 0.0033 |
| 2 | GLUTATHIONE | 1 | 0.0006 |
| 3 | ALBENDAZOLE | 1 | 0.0005 |
| 4 | NICOTINAMIDE | 1 | 0.0004 |
| 5 | PRASTERONE | 1 | 0.0004 |
| 6 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 7 | METAXALONE | 1 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | CROMOLYN SODIUM | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 1 | Corticosteroid [EPC] | 6 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 3 | Provitamin D2 Compound [EPC] | 4 |
| 4 | Anti-IgE [EPC] | 3 |
| 5 | Benzodiazepine [EPC] | 3 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 3 |
| 7 | Vitamin C [EPC] | 3 |
| 8 | Azole Antifungal [EPC] | 2 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 2 | Sulfone [EPC] | 1 | 0.0001 |
| 3 | Barbiturate [EPC] | 1 | 0.0001 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 3 | 0.0000 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |